|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Park JW, Chen M, Colombo M, Roberts LR,
Schwartz M, Chen PJ, Kudo M, Johnson P, Wagner S, Orsini LS and
Sherman M: Global patterns of hepatocellular carcinoma management
from diagnosis to death: The BRIDGE Study. Liver Int. 35:2155–2166.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mohammed MS, Ferrier G, Abouda G and
Corless L: Socio-economic deprivation significantly impacts
clinical management and survival in hepatocellular carcinoma. J
Hepatol. 68:623–625. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mancuso A and Maringhini A: Management of
hepatocellular carcinoma recurrence after liver transplant is far
from perfect. Am J Surg. 216:389–390. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
European Association For The Study Of The
Liver; European Organisation For Research And Treatment Of Cancer:
EASL-EORTC clinical practice guidelines: Management of
hepatocellular carcinoma. J Hepatol. 56:908–943. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bruix J, Raoul JL, Sherman M, Mazzaferro
V, Bolondi L, Craxi A, Galle PR, Santoro A, Beaugrand M,
Sangiovanni A, et al: Efficacy and safety of sorafenib in patients
with advanced hepatocellular carcinoma: Subanalyses of a phase III
trial. J Hepatol. 57:821–829. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Parikh ND, Marshall VD, Singal AG, Nathan
H, Lok AS, Balkrishnan R and Shahinian V: Survival and
cost-effectiveness of sorafenib therapy in advanced hepatocellular
carcinoma: An analysis of the SEER-Medicare database. Hepatology.
65:122–133. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fu J and Wang H: Precision diagnosis and
treatment of liver cancer in China. Cancer Lett. 412:283–288. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sia D, Villanueva A, Friedman SL and
Llovet JM: Liver cancer cell of origin, molecular class, and
effects on patient prognosis. Gastroenterology. 152:745–761. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dou Y, Cha DJ, Franklin JL, Higginbotham
JN, Jeppesen DK, Weaver AM, Prasad N, Levy S, Coffey RJ, Patton JG
and Zhang B: Circular RNAs are down-regulated in KRAS mutant colon
cancer cells and can be transferred to exosomes. Sci Rep.
6:379822016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Du WW, Fang L, Yang W, Wu N, Awan FM, Yang
Z and Yang BB: Induction of tumor apoptosis through a circular RNA
enhancing Foxo3 activity. Cell death and differ. 357–370. 2017.
View Article : Google Scholar
|
|
13
|
Chen J, Li Y, Zheng Q, He J, Chen B, Lyu
D, Zheng B, Xu Y, Long Z, Zhou Y, et al: Circular RNA profile
identifies circPVT1 as a proliferative factor and prognostic marker
in gastric cancer. Cancer Lett. 388:208–219. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qin M, Liu G, Huo X, Tao X, Sun X, Ge Z,
Yang J, Fan J, Liu L and Qin W: Hsa_circ_0001649: A circular RNA
and potential novel biomarker for hepatocellular carcinoma. Cancer
Biomark. 16:161–169. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ma WL, Lai HC, Yeh S, Cai X and Chang C:
Androgen receptor roles in hepatocellular carcinoma, fatty liver,
cirrhosis and hepatitis. Endocr Relat Cancer. 21:R165–R182. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shi L, Yan P, Liang Y, Sun Y, Shen J, Zhou
S, Lin H, Liang X and Cai X: Circular RNA expression is suppressed
by androgen receptor (AR)-regulated adenosine deaminase that acts
on RNA (ADAR1) in human hepatocellular carcinoma. Cell Death Dis.
8:e31712017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Soriani A, Zingoni A, Cerboni C, Iannitto
ML, Ricciardi MR, Di Gialleonardo V, Cippitelli M, Fionda C,
Petrucci MT, Guarini A, et al: ATM-ATR-dependent up-regulation of
DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic
agents results in enhanced NK-cell susceptibility and is associated
with a senescent phenotype. Blood. 113:3503–3511. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shi L, Lin H, Li G, Jin RA, Xu J, Sun Y,
Ma WL, Yeh S, Cai X and Chang C: Targeting androgen receptor
(AR)→IL12A signal enhances efficacy of sorafenib plus NK cells
immunotherapy to better suppress HCC progression. Mol Cancer Ther.
15:731–742. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ding S, Chen G, Zhang W, Xing C, Xu X, Xie
H, Lu A, Chen K, Guo H, Ren Z, et al: MRC-5 fibroblast-conditioned
medium influences multiple pathways regulating invasion, migration,
proliferation, and apoptosis in hepatocellular carcinoma. J Transl
Med. 13:2372015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Krzywinska E, Kantari-Mimoun C, Kerdiles
Y, Sobecki M, Isagawa T, Gotthardt D, Castells M, Haubold J,
Millien C, Viel T, et al: Loss of HIF-1α in natural killer cells
inhibits tumour growth by stimulating non-productive angiogenesis.
Nat Commun. 8:15972017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu Y, Kuang DM, Pan WD, Wan YL, Lao XM,
Wang D, Li XF and Zheng L: Monocyte/macrophage-elicited natural
killer cell dysfunction in hepatocellular carcinoma is mediated by
CD48/2B4 interactions. Hepatology. 57:1107–1116. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shi L, Lin H, Li G, Sun Y, Shen J, Xu J,
Lin C, Yeh S, Cai X and Chang C: Cisplatin enhances NK cells
immunotherapy efficacy to suppress HCC progression via altering the
androgen receptor (AR)-ULBP2 signals. Cancer Lett. 373:45–56. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cho EY, Chang MH, Choi YL, Lee JE, Nam SJ,
Yang JH, Park YH, Ahn JS and Im YH: Potential candidate biomarkers
for heterogeneity in triple-negative breast cancer (TNBC). Cancer
Chemother Pharmacol. 68:753–761. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Törnqvist E, Annas A, Granath B, Jalkesten
E, Cotgreave I and Öberg M: Strategic focus on 3R principles
reveals major reductions in the use of animals in pharmaceutical
toxicity testing. PLoS One. 9:e1016382014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zheng Q, Bao C, Guo W, Li S, Chen J, Chen
B, Luo Y, Lyu D, Li Y, Shi G, et al: Circular RNA profiling reveals
an abundant circHIPK3 that regulates cell growth by sponging
multiple miRNAs. Nat Commun. 7:112152016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guo JU, Agarwal V, Guo H and Bartel DP:
Expanded identification and characterization of mammalian circular
RNAs. Genome Biol. 15:4092014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
You X, Vlatkovic I, Babic A, Will T,
Epstein I, Tushev G, Akbalik G, Wang M, Glock C, Quedenau C, et al:
Neural circular RNAs are derived from synaptic genes and regulated
by development and plasticity. Nat Neurosci. 18:603–610. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Haque S and Harries LW: Circular RNAs
(circRNAs) in health and disease. Genes (Basel). 8(pii): E3532017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Abdelmohsen K, Panda AC, Munk R,
Grammatikakis I, Dudekula DB, De S, Kim J, Noh JH, Kim KM,
Martindale JL and Gorospe M: Identification of HuR target circular
RNAs uncovers suppression of PABPN1 translation by CircPABPN1. RNA
Biol. 14:361–369. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Conn VM, Hugouvieux V, Nayak A, Conos SA,
Capovilla G, Cildir G, Jourdain A, Tergaonkar V, Schmid M, Zubieta
C and Conn SJ: A circRNA from SEPALLATA3 regulates splicing of its
cognate mRNA through R-loop formation. Nat Plants. 3:170532017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li Z, Huang C, Bao C, Chen L, Lin M, Wang
X, Zhong G, Yu B, Hu W, Dai L, et al: Exon-intron circular RNAs
regulate transcription in the nucleus. Nat Struct Mol Biol.
22:256–264. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huergo-Zapico L, Acebes-Huerta A,
López-Soto A, Villa-Álvarez M, Gonzalez-Rodriguez AP and Gonzalez
S: Molecular bases for the regulation of NKG2D ligands in cancer.
Front Immunol. 5:1062014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shin S, Kim M, Lee SJ, Park KS and Lee CH:
Trichostatin A sensitizes hepatocellular carcinoma cells to
enhanced NK cell-mediated killing by regulating immune-related
genes. Cancer Genomics Proteomics. 14:349–362. 2017.PubMed/NCBI
|
|
35
|
Xu T, Cui T, Peng L, Kong S, Zou J and
Tian X: The anti-hepatocellular carcinoma activity of Mel-P15 is
mediated by natural killer cells. Oncol Lett. 14:6901–6906.
2017.PubMed/NCBI
|
|
36
|
Zhu L, Li XJ, Kalimuthu S, Gangadaran P,
Lee HW, Oh JM, Baek SH, Jeong SY, Lee SW, Lee J and Ahn BC: Natural
killer cell (NK-92MI)-based therapy for pulmonary metastasis of
anaplastic thyroid cancer in a nude mouse model. Front Immunol.
8:8162017. View Article : Google Scholar : PubMed/NCBI
|
